Previous research confirmed that overexpressing HSP72 facilitated a satisfactory prognosis of cerebral ischemia–reperfusion injury, which may be attributed to c-Jun N-terminal kinase 3 signaling pathway inhibition and Akt1 activation (20). The gene discussed is MAPK10; the disease is brain ischemia.